StockWatch
·
Specialty Chemicals
Board Meeting12 Aug 2026, 04:30 pm

Valiant Organics MD Re-appointed; Board Approves Financial Results

AI Summary

Valiant Organics Ltd announced that its Board of Directors, at a meeting held on August 12, 2026, approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board also approved the re-appointment of Shri Sathiababu K. Kallada as Managing Director for a three-year term commencing May 24, 2027, subject to shareholder approval. Additionally, the company plans to shift its registered office, subject to shareholder consent. The meeting also covered the limited review report of the statutory auditors.

Key Highlights

  • Re-appointment of Managing Director for a 3-year term approved.
  • Unaudited standalone and consolidated financial results for Q1 FY27 declared.
  • Board approved shifting of registered office, pending shareholder nod.
  • Limited Review Report from statutory auditors was also approved.